NRAS and melanoma: Here, in melanocytes and in melanoma cell lines, we have studied the phosphorylation status of key PKB, mTOR and MAPK pathway components downstream of PTEN, PIK3CA, NRAS and BRAF mutations to determine whether the activity of the signalling pathways correlates with the upstream mutation.